Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederclinicaltrials.gov
ClinicalTrials.gov: Olutasidenib | Last update posted in the last 14 days
Get the latest updates from ClinicalTrials.gov: Olutasidenib | Last update posted in the last 14 days directly as they happen.
Follow now < 10 followers
Latest posts
Last updated about 10 hours ago
Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
4 days ago
Conditions: AML (Acute Myeloid Leukemia); Glioma; Cholangiocarcinoma; Solid Tumor Malignancies Interventions: Drug...
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
4 days ago
Conditions: Acute Myeloid Leukemia; Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm...
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
6 days ago
Conditions: Acute Myeloid Leukemia; Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm...
Olutasidenib in Relapsed IDH1 Mutated AML Patients Who Have Previously Received Venetoclax
8 days ago
Conditions: IDH1 Mutation; Relapsed / Refractory AML Interventions: Drug: Olutasidenib; Drug: Azacitidine...
A Clinical Trial of Olutasidenib in Patients With Acute Myeloid Leukemia
13 days ago
Conditions: Relapsed or Refractory IDH1 Mutation-Positive Acute Myeloid Leukemia Interventions: Drug: Olutasidenib...
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
14 days ago
Conditions: Acute Myeloid Leukemia; Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm...
A Phase II Clinical Trial of Olutasidenib in Patients With Acute Myeloid Leukemia
18 days ago
Conditions: Relapsed or Refractory IDH1 Mutation-Positive Acute Myeloid Leukemia Interventions: Drug: Olutasidenib...
Phase 1b/2 Study of Decitabine and Venetoclax in Combination With the Targeted Mutant IDH1 Inhibitor Olutasidenib
20 days ago
Conditions: Mutant IDH1 Inhibitor Olutasidenib Interventions: Drug: Olutasidenib; Drug: Venetoclax; Drug: Decitabine...
A Phase 2 Study Evaluating Olutasidenib in Combination With Hypomethylating Agents in Patients With IDH1-mutated Higher-risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Advanced Myeloproliferative Neoplasm
20 days ago
Conditions: Chronic Myelomonocytic Leukemia; Advanced Myeloproliferative Neoplasms; IDH1-mutated Higher-Risk Myelodysplastic Syndromes Interventions...
Phase 1/1b Trial Of Olutasidenib And Ziftomenib For NPM1 And IDH1 Co-Mutated Acute Myeloid Leukemia
25 days ago
Conditions: Acute Myeloid Leukemia Interventions: Drug: Ziftomenib; Drug: Olutasidenib Sponsors: M.D. Anderson...
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
25 days ago
Conditions: Acute Myeloid Leukemia; Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm...
Testing the Use of an IDH1 Inhibitor, Olutasidenib, in Acute Myeloid Leukemia Added to ASTX727 and Venetoclax; in High-Risk MDS Added to ASTX727; and Alone in Low Risk MDS (A MyeloMATCH Treatment Substudy)
27 days ago
Conditions: Acute Myeloid Leukemia; Myelodysplastic Syndrome Interventions: Procedure: Biospecimen Collection; Procedure: Bone...